8,881 results on '"Vertex Pharmaceuticals Inc."'
Search Results
2. Vertex Pharmaceuticals price target lowered by $10 at Oppenheimer, here's why
3. Vertex Pharmaceuticals price target raised by $85 at UBS, here's why
4. Vertex Pharmaceuticals initiated with neutral view at Scotiabank, here's why
5. Vertex Pharmaceuticals price target lowered by $9 at BofA, here's why
6. Vertex Pharmaceuticals resumed with a Market Perform at Raymond James
7. Vertex Pharmaceuticals price target raised by $12 at RBC Capital, here's why
8. Vertex Pharmaceuticals price target raised by $12 at Morgan Stanley, here's why
9. Vertex Pharmaceuticals presents vanzacaftor/tezacaftor/deutivacaftor data
10. Vertex treatment of myotonic dystrophy type 1 granted FDA orphan designation
11. Shopify, Spotify added to 'Signature Picks' portfolio at Wells Fargo
12. Is Vertex Pharmaceuticals Stock Outperforming the Nasdaq?
13. Exagamglogene Autotemcel for Transfusion-Dependent β-Thalassemia.
14. Exagamglogene Autotemcel: First Approval.
15. Vertex Pharmaceuticals Incorporated SWOT Analysis.
16. Event Brief of Vertex Pharmaceuticals Inc at Morgan Stanley Global Healthcare Conference - Final
17. Vertex Pharmaceuticals Inc at Morgan Stanley Global Healthcare Conference - Final
18. Eli Lilly named new top large pharma pick at Wells Fargo
19. Vertex Pharmaceuticals price target raised by $42 at Truist, here's why
20. Vertex Pharmaceuticals price target raised by $50 at Oppenheimer, here's why
21. Vertex Pharmaceuticals Inc. Files SEC Form 4, Statement of Changes in Beneficial Ownership of Securities: (Jul. 17, 2024)
22. Vertex Pharmaceuticals price target raised by $35 at Piper Sandler, here's why
23. Vertex Pharmaceuticals price target raised by $25 at TD Cowen, here's why
24. Vertex Pharmaceuticals price target raised by $100 at H.C. Wainwright, here's why
25. Notable companies reporting after market close
26. Vertex says FDA accepted suzetrigine new drug application
27. Vertex Pharmaceuticals expands drug discovery collaboration with Genomics
28. Vertex Pharmaceuticals announces FDA acceptance of triple combination therapy
29. Verve Therapeutics appoints Nia Tatsis, Jodie Morrison to board
30. Vertex Pharmaceuticals price target raised by $15 at Wells Fargo, here's why
31. Vertex Pharmaceuticals price target raised by $85 at Argus, here's why
32. Vertex Pharmaceuticals Inc. Files SEC Form 4, Statement of Changes in Beneficial Ownership of Securities: (May 29, 2024)
33. Vertex Pharmaceuticals Inc. Files SEC Form 4, Statement of Changes in Beneficial Ownership of Securities: (May 24, 2024)
34. Vertex Pharmaceuticals price target lowered by $3 at RBC Capital, here's why
35. Vertex Pharmaceuticals Inc. Files SEC Form SC TO-T/A, Tender Offer Statement By Third Party: (May 20, 2024)
36. Vertex Pharmaceuticals Inc. Files SEC Form 3, Initial Statement of Beneficial Ownership of Securities: (May 17, 2024)
37. Vertex Pharmaceuticals presents new data at ECFS on TRIKAFTA treatment
38. Vertex Pharmaceuticals Inc. Files SEC Form SC TO-T/A, Tender Offer Statement By Third Party: (May 10, 2024)
39. Vertex Pharmaceuticals price target raised by $20 at BMO Capital, here's why
40. Vertex Pharmaceuticals affirms FY4 revenue view of $10.55B-$10.75
41. Vertex Pharmaceuticals Inc. Files SEC Form PX14A6G, Notice of Exempt Solicitation Submitted By Non-management: (Apr. 16, 2024)
42. Vertex Pharmaceuticals Inc. Files SEC Form DEF 14A, Other Definitive Proxy Statements: (Apr. 4, 2024)
43. Vertex Pharmaceuticals Inc. Files SEC Form ARS, Annual Report To Security Holders: (Apr. 4, 2024)
44. Vertex announces European Commission approval for KALYDECO
45. Vertex and TreeFrog join forces to enhance type 1 diabetes cell therapy production
46. Vertex announces advancements of pain signal inhibitor, suzetrigine in acute and neuropathic pain
47. Vertex Pharmaceuticals announces advancements in suzetrigine pain program
48. Alpine Immune Sciences just downgraded at TD Cowen, here's why
49. Novartis reports results from interim analysis of Phase 3 APPLAUSE-IgAN study
50. Alpine Immune Sciences just downgraded at H.C. Wainwright, here's why
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.